These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6389592)

  • 41. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
    Chen XJ; Qiao J; Xiao BG; Lu CZ
    J Neurol; 2004 Aug; 251(8):1006-11. PubMed ID: 15316806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
    Ichikawa Y; Shimizu H; Yoshida M; Arimori S
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Computed tomography of the mediastinum in myasthenia gravis. Normal findings, thymic hyperplasia, thymomas (author's transl)].
    Gürtler KF; Janzen RW; Hagemann J; Otto HF
    Rofo; 1982 Jan; 136(1):35-40. PubMed ID: 6212407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Thymectomy in myasthenia gravis].
    Schumpelick V; Janzen RW
    Dtsch Med Wochenschr; 1984 Jul; 109(30):1166-72. PubMed ID: 6086265
    [No Abstract]   [Full Text] [Related]  

  • 45. Thymoma--morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases.
    Quintanilla-Martinez L; Wilkins EW; Ferry JA; Harris NL
    Hum Pathol; 1993 Sep; 24(9):958-69. PubMed ID: 8253462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor.
    Priola AM; Priola SM
    Clin Radiol; 2014 May; 69(5):e230-45. PubMed ID: 24581970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating immune complexes in myasthenia gravis: a study in relation to thymectomy, clinical severity and thymus histology.
    Bartoloni C; Guidi L; Scoppetta C; Tonali P; Bartoccioni E; Flamini G; Gambassi G; Terranova T
    J Neurol Neurosurg Psychiatry; 1981 Oct; 44(10):901-5. PubMed ID: 7310408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
    Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
    Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinicopathologic analysis of 52 cases of thymic epithelial tumor].
    Ma YQ; Miao N; Abulajiang G; Li QX; Liu X; Zhang W; Wang CF; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):249-54. PubMed ID: 20654124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum antibodies and monoclonal antibodies secreted by thymic B-cell clones from patients with myasthenia gravis define striational antigens.
    Williams CL; Lennon VA; Momoi MY; Howard FM
    Ann N Y Acad Sci; 1987; 505():168-79. PubMed ID: 3500666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Titin transcripts in thymomas.
    Skeie GO; Freiburg A; Kolmerer B; Labeit S; Aarli JA; Appiah-Boadu S; Gilhus NE
    J Autoimmun; 1997 Dec; 10(6):551-7. PubMed ID: 9451594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Galectin-1 is expressed by thymic epithelial cells in myasthenia gravis.
    Hafer-Macko C; Pang M; Seilhamer JJ; Baum LG
    Glycoconj J; 1996 Aug; 13(4):591-7. PubMed ID: 8872116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human myasthenia gravis thymic myoid cells: de novo immunohistochemical and intracellular electrophysiological studies.
    Furuya A; Kobayashi T; Kameda N; Tsukagoshi H
    J Neurol Sci; 1991 Feb; 101(2):208-20. PubMed ID: 2033406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Morphometrical and immunohistochemical analysis of cortical and medullary thymoma: its correlation with invasiveness and association with myasthenia gravis].
    Nomori H; Ishihara T; Torikata C
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jan; 38(1):93-100. PubMed ID: 1691772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thymic myoid cells--stimulants and/or targets of autoimmune myasthenia gravis.
    Müller-Hermelink HK; Kirchner T; Hoppe F; Demel S
    Monogr Allergy; 1988; 25():68-74. PubMed ID: 2459614
    [No Abstract]   [Full Text] [Related]  

  • 57. [Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance].
    Suzuki S
    Brain Nerve; 2011 Jul; 63(7):705-12. PubMed ID: 21747140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myasthenia gravis: monoclonal antihuman acetylcholine receptor antibodies used to analyze antibody specificities and responses to treatment.
    Whiting PJ; Vincent A; Newsom-Davis J
    Neurology; 1986 May; 36(5):612-7. PubMed ID: 3703260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies in myasthenia gravis: immunofluorescent tagging of muscle striation with antibody from serums of 256 myasthenic patients.
    Osserman KE; Weiner LB
    Ann N Y Acad Sci; 1965 Jun; 124(2):730-43. PubMed ID: 5320504
    [No Abstract]   [Full Text] [Related]  

  • 60. Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis.
    Chan KH; Kwan JS; Ho PW; Ho SL; Chui WH; Chu AC; Ho JW; Zhang WY; Kung MH
    J Neuroimmunol; 2010 Oct; 227(1-2):178-84. PubMed ID: 20728226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.